Non-Diabetic Patients: Clinical Trials

5 trials for Non-Diabetic Patients, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 active not recruiting, 1 not yet recruiting, 1 terminated. 2 Phase 4, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 42Active not recruiting 1, Recruiting 1
Phase 21Not yet recruiting 1

Follow Non-Diabetic Patients: new trials by email Literature Review of Non-Diabetic Patients trials Research Report on Non-Diabetic Patients

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
SGLT2i Effect on PTDM Development and Kidney Allograft Function in Non-diabetic Kidney Transplant Recipients: A Randomized, Doubleblind, Placebo Controlled, National Multicenter Trial
SGLT2i, Placebo - Kidney Transplant Recipient, Sodium Glucose Co-Transporter 2 Inhibitors
Phase 2Not yet recruitingOdense University Hospital1842026-09-012026-07-02
Association Between Overt and Sub-clinical Primary Hypothyroidism and Metabolic Dysfunction-Associated Steatoic Liver Disease in Non-Diabetic Patients
FibroScan, Thyroid Function Assessment - Overt, Sub-clinical
RecruitingSohag University2002026-03-012026-06-02
SGLT2i Safety and Efficacy on Kidney Allograft Function in Non-diabetic Kidney Transplant Recipients
SGLT-2 inhibitor, Placebo - Kidney Transplantation Recipients, Sodium-Glucose Transporter 2 Inhibitors
Phase 4RecruitingOdense University Hospital882025-09-012025-08-27
Acute Effects of SGLT2 Inhibitor on Kidney Allograft Oxygen Tension
JARDIANCE 25mg, Placebo - Kidney Transplantation Recipients, Magnetic Resonance Imaging (MRI)
Phase 4Active not recruitingOdense University Hospital82025-03-272025-07-31
Role of Tissue Oxygenation and the miR-210 Gene In Wound Healing
Non-Diabetic Patients, Wound Leg
TerminatedChandan Sen542015-10-012024-04-25

Narrower conditions

Hypothyroidism (1)  ·  Wounds and Injuries (1)

Broader conditions

Endocrine System Diseases (1)  ·  Thyroid Diseases (1)

Interventions

Sodium-Glucose Transporter 2 Inhibitors (1)  ·  dapagliflozin (1)  ·  empagliflozin (1)

Sponsors

Odense University Hospital (3)  ·  Chandan Sen (1)  ·  Sohag University (1)

Countries

Denmark (3)  ·  Egypt (1)  ·  United States (1)

Top investigators

Lotte B Lange, MD (3)  ·  Chandan K Sen, PhD (1)

Results publications

PMID 41462489